Effectiveness of Self-guided App-Based Virtual Reality Cognitive Behavior Therapy for Acrophobia: A Randomized Clinical Trial.


Journal

JAMA psychiatry
ISSN: 2168-6238
Titre abrégé: JAMA Psychiatry
Pays: United States
ID NLM: 101589550

Informations de publication

Date de publication:
01 07 2019
Historique:
pubmed: 21 3 2019
medline: 17 6 2020
entrez: 21 3 2019
Statut: ppublish

Résumé

Globally, access to evidence-based psychological treatment is limited. Innovative self-help methods using smartphone applications and low-cost virtual reality have the potential to significantly improve the accessibility and scalability of psychological treatments. To examine the effectiveness of ZeroPhobia, a fully self-guided app-based virtual reality cognitive behavior therapy (VR CBT) using low-cost (cardboard) virtual reality goggles compared with a wait-list control group and to determine its user friendliness. In a single-blind randomized clinical trial, participants were enrolled between March 24 and September 28, 2017, and randomly assigned (1:1) by an independent researcher to either VR CBT app or a wait-list control group. A total of 193 individuals aged 18 to 65 years from the Dutch general population with acrophobia symptoms and access to an Android smartphone participated. The 6 animated modules of the VR-CBT app and gamified virtual reality environments were delivered over a 3-week period in participants' natural environment. Assessments were completed at baseline, immediately after treatment, and at 3-month follow-up. Analysis began April 6, 2018, and was intention to treat. Self-guided app-based VR CBT. The primary outcome measure was the Acrophobia Questionnaire. The hypothesis was formulated prior to data collection. In total, 193 participants (129 women [66.84%]; mean [SD] age, 41.33 [13.64] years) were randomly assigned to intervention (n = 96) or a wait-list control group (n = 97). An intent-to-treat analysis showed a significant reduction of acrophobia symptoms at posttest at 3 months for the VR-CBT app compared with the controls (b = -26.73 [95% CI, -32.12 to -21.34]; P < .001; d = 1.14 [95% CI, 0.84 to 1.44]). The number needed to treat was 1.7. Sensitivity and robustness analysis confirmed these findings. Pretreatment attrition was 22 of 96 (23%) because of smartphone incompatibility. Of the 74 participants who started using the VR-CBT app, 57 (77%) completed the intervention fully. A low-cost fully self-guided app-based virtual reality cognitive behavioral therapy with rudimentary virtual reality goggles can produce large acrophobia symptom reductions. To our knowledge, this study is the first to show that virtual reality acrophobia treatment can be done at home without the intervention of a therapist. Trialregister.nl identifier: NTR6442.

Identifiants

pubmed: 30892564
pii: 2728184
doi: 10.1001/jamapsychiatry.2019.0219
pmc: PMC6583672
doi:

Banques de données

NTR
['NTR6442']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

682-690

Références

J Consult Clin Psychol. 1991 Feb;59(1):12-9
pubmed: 2002127
Health Serv Res. 2001 Dec;36(6 Pt 1):987-1007
pubmed: 11775672
J Anxiety Disord. 2019 Jan;61:27-36
pubmed: 30287083
BMC Med Res Methodol. 2004 Nov 09;4:26
pubmed: 15535880
Lancet Psychiatry. 2018 Aug;5(8):625-632
pubmed: 30007519
Behav Res Ther. 2004 Feb;42(2):229-39
pubmed: 14975783
Clin Epidemiol. 2017 Mar 15;9:157-166
pubmed: 28352203
J Med Internet Res. 2013 May 13;15(5):e82
pubmed: 23669884
Behav Res Ther. 2017 Jan;88:19-25
pubmed: 28110672
Psychol Med. 2007 Jul;37(7):1047-59
pubmed: 17335637
Behav Res Ther. 2002 May;40(5):509-16
pubmed: 12038644
JAMA Psychiatry. 2017 Apr 1;74(4):351-359
pubmed: 28241179
Cogn Behav Ther. 2017 Sep;46(5):404-420
pubmed: 28270059
J Health Soc Behav. 1978 Mar;19(1):2-21
pubmed: 649936
Soc Psychiatry Psychiatr Epidemiol. 2010 Dec;45(12):1161-6
pubmed: 19888542
Compr Psychiatry. 2007 Mar-Apr;48(2):132-6
pubmed: 17292703
J Anxiety Disord. 2011 Oct;25(7):896-902
pubmed: 21641766
J Anxiety Disord. 2019 Jan;61:18-26
pubmed: 30646997
Trials. 2018 Aug 9;19(1):433
pubmed: 30092844
Sci Rep. 2018 Jul 9;8(1):10323
pubmed: 29985400
World Psychiatry. 2014 Feb;13(1):4-11
pubmed: 24497236
PLoS One. 2011 Apr 27;6(4):e19070
pubmed: 21556361
Soc Psychiatry Psychiatr Epidemiol. 2012 Feb;47(2):203-13
pubmed: 21197531
J Consult Clin Psychol. 1988 Dec;56(6):893-7
pubmed: 3204199
Depress Anxiety. 2012 Feb;29(2):85-93
pubmed: 22065564
J Anxiety Disord. 2019 Jan;61:3-17
pubmed: 30057346
J Affect Disord. 2013 Jul;149(1-3):1-13
pubmed: 23528438
BJPsych Open. 2018 Jul 25;4(4):307-312
pubmed: 30083384
J Med Internet Res. 2009 Jul 24;11(3):e19
pubmed: 19632977
Acta Psychiatr Scand. 2004 Jun;109(6):426-33
pubmed: 15117287
Behav Res Ther. 1989;27(5):561-7
pubmed: 2573337
Soc Psychiatry Psychiatr Epidemiol. 2008 Mar;43(3):200-8
pubmed: 18060338
JAMA. 2016 May 3;315(17):1854-63
pubmed: 27139058
Med J Aust. 2017 Apr 3;206(6):263-267
pubmed: 28359010
Int J Methods Psychiatr Res. 2012 Sep;21(3):169-84
pubmed: 22865617
J Behav Ther Exp Psychiatry. 2008 Sep;39(3):250-61
pubmed: 17720136
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Behav Res Ther. 2015 Nov;74:18-24
pubmed: 26355646
Behav Ther. 2013 Dec;44(4):548-58
pubmed: 24094780
Clin Psychol Rev. 2008 Jul;28(6):1021-37
pubmed: 18410984

Auteurs

Tara Donker (T)

Department of Clinical, Neuro- and Developmental Psychology, Section Clinical Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Amsterdam Public Health Research Institute Amsterdam, Amsterdam, the Netherlands.

Ilja Cornelisz (I)

Department of Education Sciences, Section Methods and Statistics, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Amsterdam Center for Learning Analytics, the Netherlands.

Chris van Klaveren (C)

Department of Education Sciences, Section Methods and Statistics, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Amsterdam Center for Learning Analytics, the Netherlands.

Annemieke van Straten (A)

Department of Clinical, Neuro- and Developmental Psychology, Section Clinical Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Amsterdam Public Health Research Institute Amsterdam, Amsterdam, the Netherlands.

Per Carlbring (P)

Department of Psychology, University Stockholm, Stockholm, Sweden.
Department of Psychology, University of Southern Denmark, Odense, Denmark.

Pim Cuijpers (P)

Department of Clinical, Neuro- and Developmental Psychology, Section Clinical Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Amsterdam Public Health Research Institute Amsterdam, Amsterdam, the Netherlands.

Jean-Louis van Gelder (JL)

Department of Psychology of Conflict, Risk and Safety, University of Twente, Enschede, Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH